Polansky Hanan, Lori Gillad
The Center for the Biology of Chronic Disease, Valley Cottage, NY, USA.
J Evid Based Integr Med. 2020 Jan-Dec;25:2515690X20932523. doi: 10.1177/2515690X20932523.
The coronavirus (SARS-CoV-2), which causes COVID-19, is a betacoronavirus closely related to the human severe acute respiratory syndrome (SARS)-coronavirus (SARS-CoV). The recent COVID-19 outbreak created an urgent need for treatment. To expedite the development of such treatment, pharmaceutical companies and government agencies are currently testing several existing drugs for their effect on the virus. Gene-Eden-VIR and Novirin are natural, broad-spectrum, antiviral treatments proven to be safe and effective in several clinical studies. In this article, we present evidence indicating that the 5 Gene-Eden-VIR/Novirin ingredients have anti-betacoronavirus, and specifically, anti-SARS-CoV effects. We consider this evidence as a first indication of the anti-coronavirus effects of Gene-Eden-VIR/Novirin. Next, we are planning to conduct a clinical study with users of the treatments to test the effects of Gene-Eden-VIR/Novirin on individuals at risk and those infected with the virus.
导致新冠肺炎的冠状病毒（SARS-CoV-2）是一种与人类严重急性呼吸综合征（SARS）冠状病毒（SARS-CoV）密切相关的β冠状病毒。近期新冠肺炎疫情的爆发使得对治疗方法产生了迫切需求。为加快此类治疗方法的研发，制药公司和政府机构目前正在测试几种现有药物对该病毒的作用。Gene-Eden-VIR和诺维琳是天然的广谱抗病毒疗法，已在多项临床研究中被证明是安全有效的。在本文中，我们提供证据表明Gene-Eden-VIR/诺维琳的5种成分具有抗β冠状病毒的作用，具体而言，具有抗SARS-CoV的作用。我们将此证据视为Gene-Eden-VIR/诺维琳具有抗冠状病毒作用的首个迹象。接下来，我们计划对这些疗法的使用者进行一项临床研究，以测试Gene-Eden-VIR/诺维琳对有感染风险的个体以及感染该病毒的个体的作用。
